Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Which Investors Should Avoid Robo Advisors outlines situations where automated options may underperform. This intro highlights alternatives to consider.
28,175 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
As AI demand drives 24/7 data-center power, investors pivot from solar bets to nuclear plays. The nuclear fund is del...
SpaceX stock has pulled back after a brisk IPO run, trading in the low to mid 140s as of today. This report breaks do...
A fresh, per-capita violence ranking shifts attention away from familiar conflict zones, signaling new risk dynamics ...
As the 10-year yield hovers near 4.4%, many investors chase top-yield REITs for income. The real cost chasing reit be...
Adobe's AI push lifts revenue and unlocks upside for investors as shares hover near $253. This adobe price prediction...
The Federal Reserve holds rates steady, but new chair Kevin Warsh’s hawkish cues spurred a late-day market pullback. ...
SoftBank CEO Masayoshi Son says global AI demand will need roughly $5 trillion each year to scale infrastructure, arg...
Robert Kiyosaki says he bought more BTC, doubling down on a view that bitcoin could eventually outperform gold amid m...
Zoom's post-pandemic growth trajectory remains uncertain as investors weigh AI opportunities and competition. This pi...
Fuel shortages and higher prices threaten summer trips as airlines trim routes. Investors are reassessing bets on tra...
"amazon over 1.56 million" workers sit beside about 1 million robots in Amazon’s sprawling network, signaling a shift...